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Human endogenous retroviruses (HERVs) arise from ancient infections of the host
germline cells by exogenous retroviruses, constituting 8% of the human genome. Elevated
level of envelope transcripts from HERVs-W has been detected in CSF, plasma and
brain tissues from patients with Multiple Sclerosis (MS), most of them from Xq22.3,
15q21.3, and 6q21 chromosomes. However, since the locus Xq22.3 (ERVWE2) lack the
5′ LTR promoter and the putative protein should be truncated due to a stop codon,
we investigated the ERVWE2 genomic loci from 84 individuals, including MS patients
with active HERV-W expression detected in PBMC. In addition, an automated search
for promoter sequences in 20 kb nearby region of ERVWE2 reference sequence was
performed. Several putative binding sites for cellular cofactors and enhancers were found,
suggesting that transcription may occur via alternative promoters. However, ERVWE2
DNA sequencing of MS and healthy individuals revealed that all of them harbor a stop
codon at site 39, undermining the expression of a full-length protein. Finally, since plaque
formation in central nervous system (CNS) of MS patients is attributed to immunological
mechanisms triggered by autoimmune attack against myelin, we also investigated the
level of similarity between envelope protein and myelin oligodendrocyte glycoprotein
(MOG). Comparison of the MOG to the envelope identified five retroviral regions similar
to the Ig-like domain of MOG. Interestingly, one of them includes T and B cell epitopes,
capable to induce T effector functions and circulating Abs in rats. In sum, although no
DNA substitutions that would link ERVWE2 to the MS pathogeny was found, the similarity
between the envelope protein to MOG extends the idea that ERVEW2 may be involved on
the immunopathogenesis of MS, maybe facilitating the MOG recognizing by the immune
system. Although awaiting experimental evidences, the data presented here may expand
the scope of the endogenous retroviruses involvement on MS pathogenesis.
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INTRODUCTION
Multiple Sclerosis (MS) is an immune-mediated disease of the
central nervous system (CNS), but precise immunologic mech-
anisms involved in the induction and chronic course of MS are
still poorly understood. Epidemiological studies have shown both
environmental and genetic factors to display an association with
this disease. Genetic predisposition includes some familiar inher-
ited risk, the association to the HLA class II DRB1∗1501 and
DRB5∗0101 alleles in Caucasians (Gregersen et al., 2006) and
an abnormal autoimmune reaction against the prominent CNS
myelin antigens such as the myelin oligodendrocyte glycopro-
tein (MOG). MOG is a transmembrane protein expressed in
oligodendrocytes with extracellular Ig domain that works as an
important CNS-specific autoantigen. Nevertheless, despite evi-
dence of humoral and T cell-mediated responses to myelin basic
protein (MBP) and MOG (Bernard and de Rosbo, 1991), unam-
biguous relationship between myelin reactivity and disease has yet
to be demonstrated.
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An infectious etiology ofMS has been also postulated, and over
several years a number of different viruses have been suggested to
trigger immunopathology. One mechanism by which virus infec-
tion may lead to autoimmune reaction is via expression of super-
antigens. Superantigens are molecules that induce activation and
proliferation of nonspecific T cells, often leading to a chronic
inflammatory response. In addition to the superantigens, molec-
ular mimicry-activation of autoreactive T cells by viral epitopes
that are shared or cross-reactive with self-antigens could also lead
to an autoimmune response (Colmegna and Garry, 2006).
Increased antibody titers were detected for Epstein-Barr,
Varicella-Zoster, and Rubella Viruses, whereas specific proteins of
human endogenous retrovirus (HERV), particularly fromHERV-
W family were evidenced in blood cells and brain lesions of MS
patients (Antony et al., 2004a; Mameli et al., 2007; Owens et al.,
2011; Perron et al., 2012). Also, EBV and HERV-W-associated
superantigens where already hypothesized to contribute to MS
pathogeny (Tai et al., 2008; Antony et al., 2011).
HERVs arise from ancient infections of the host germline cells
by exogenous retroviruses and today, constitute about 8% of the
whole human genome (Lander et al., 2001). A number of studies
have found increased expression of HERV genes from different
families in individuals presenting autoimmune diseases (Bannert
and Kurth, 2004; Ehlhardt et al., 2006; Schulz et al., 2006; Perron
and Lang, 2010).
Elevated RNA levels of MRSV (Multiple Sclerosis associated
Retrovirus), a prototypic element defining a subtype fromHERV-
W family, have been frequently detected in CSF, plasma and
brain tissues from patients with MS but rarely in healthy con-
trol individuals. (Perron et al., 1997, 2012; Garson et al., 1998;
Antony et al., 2004b; Dolei and Perron, 2009). MSRV sequences
were found to be associated with extracellular retroviral particles
in MS, but may also originate or be co-activated from differ-
ent proviral copies (Komurian-Pradel et al., 1999), besides also
diverge in quantity and identity between individuals (Mameli
et al., 2009; Perron et al., 2012). Recently, it was described that
many HERV-W envelope transcripts from MS patients derived
from Xq22.3, 15q21.3, and 6q21 (Laufer et al., 2009). Although
the genomic Xq22.3 MRSV/env (ERVWE2) has no 5′ LTR pro-
moter and is truncated due to a stop codon (TGA) at position 39,
the authors found several transcripts associated to this locus, but
harboring a tryptophan (TGG) at site 39 instead. These findings
open the possibility for an envelope protein encoded by anHERV-
W element of the MSRV subtype (Mameli et al., 2009) plays a role
in MS.
Thus, given the clear association of HERV-W elements to MS,
the aim of this study was to investigate the putative involve-
ment of Xq22.3 HERV-Wenv locus (ERVWE2) in MS pathogeny
combining molecular and bioinformatics tools. This report also
presents in silico evidences that a retroviral envelope expression
could trigger the adaptive immune response against brain anti-
gens. Although awaiting formal and conclusive evidence, our data
may have important implications for redefining the breadth of the
ERVWE2 involvement on autoimmunity. Furthermore, since the
contribution of the endogenous retroviruses to human diseases
remains largely unexplored, dissemination of knowledge at this
level is worth in this domain.
PATIENTS ANDMETHODS
SAMPLES
The current project was conducted after Hospital das Clínicas -
University of Sao Paulo’s Institutional Review Board (CAPPesq)
approval, under protocol #0166/11. Written informed consent
was obtained from all participants.
Total blood was obtained from 47 patients with MS diagnosed
according to McDonald criteria, revised by Polman et al. (2011).
We also included 37 healthy individuals with no familiar his-
tory of MS. The cohort investigated included patients classified
as relapse—remitting, primary, and secondary progressive MS.
REVERSE TRANSCRIPTION AND HERV-W ENVELOPE REAL TIME
DETECTION
HERV-W envelope expression was investigated in a subset of
samples (10 of 47MS patients) that had peripheral blood
mononuclear cells (PBMC) stored. As a control, envelope tran-
scripts were investigated in PBMC from the same number
of healthy individuals (n = 10). Total RNA was isolated from
cells using Trizol LSReagent® (Invitrogen Corporation, Carlsbad,
CA). Samples were pre-treated twice with DNAse to elimi-
nate traces of genomic DNA as a source of putative HERV
amplified sequences. Reverse transcriptase (RT) was performed
with High-Capacity cDNA Reverse Transcription Kit (Applied
Biosystems) and amplifications without RT enzyme were done
in parallel to check for remaining DNA on samples. HERV-W
envelope primers and RT-qPCR conditions were set accord-
ing to previous description (Nellåker et al., 2006), 50ng of
cDNA was used as input for RT-qPCR and the relative expres-
sion was normalized according to Beta-actin expression through
Human ACTB (Beta Actin) Endogenous Control kit (Applied
Biosystems).
ERVWE2 AMPLIFICATION AND SEQUENCING
After genomic DNA extraction using QIAamp DNA Blood
Mini kit (Qiagen), a 896 base pairs (bp) of envelope region
corresponding to nucleotides 21231 to 22127 of human
chromosome Xq22.3 MRSV locus (ERVWE2, GenBank ID
AL390039.10) was amplified by PCR using following specific
primers: HW_MSchX_F-CTGTTGGACTTACTTCACCCA and
HW_ MSchX _R- TGAAGAACGTATCCAGCCTACA. The ther-
mal profile for amplification was 38 cycles as follows: 94◦C for
45 s, 52◦C for 1min, and 72◦C for 1min. PCR products were
purified using PEG 20% (polyethylene glycol) and sequenced
on an ABI 3100 genetic analyzer (Applied Biosystems, Foster
City, CA). The eletropherograms were analyzed and consensus
sequences were achieved with CodonCode Aligner v.3.0 (available
at http://www.codoncode.com/).
SEQUENCING AND BIOINFORMATIC ANALYSIS
Nucleotide sequences obtained from MS and healthy individu-
als were manually edited and aligned to reference sequences from
ERVWE2 DNA and transcripts obtained by Laufer et al. (2009)
in SeAl (available at http://tree.bio.ed.ac.uk/software/seal/). The
aligned dataset was translated to amino acid and the putative
substitution TGA/TGG at codon 39 was visually inspected. In
addition to the ERVWE2, DNA sequences from MRSV envelope
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gene present in other chromosomes were also retrieved using
BLAT tool (www.genome.ucsc.edu). Sequences were manually
aligned, translated and visually inspected.
Since ERVWE2 lacks the 5′LTR promoter, we performed
an automated search for alternative promoters and regulatory
regions in 10 kb region up and downstream of the envelope gene
in the GenBank reference sequence (AL39009.10, position 10079
to 32008) using Cister (Cis-element Cluster Finder) (Frith et al.,
2001) and PromoterScan (http://www-bimas.cit.nih.gov/molbio/
proscan/) tools.
Since the HERV-W envelope can work as autoantigen and
hypothetically, serve as trigger for autoimmune disease, we
also evaluated the level of similarity between HERV-W enve-
lope protein and the different isoforms of MBP and MOG
using Blastp tool (ftp://ftp.ncbi.nlm.nih.gov/blast/executables/
blast+/LATEST/). Some search parameters were adjusted to
increase the probability of detecting significant matches (i.e.,
Expected threshold = 11 and Gap costs: existence = 10 and
extension = 1). Prediction of cleavage sites for human pro-
teases was performed in MOG and HERV-W envelope using
PAProc I (http://www.paproc.de/). Finally, NetGene2 (available
at: http://www.cbs.dtu.dk/ services/NetGene2/output.php) was
used to predict putative donor and acceptor splicing sites in the
ERVWE2.
RESULTS
Forty-seven patients with clinically definite MS and 37 healthy
individuals were enrolled in the study. Among the patients, 6 were
male and 41 female, with mean age of 27 years. Volunteers were
classified according to the type ofMS as follows: 40 had relapsing-
remitting clinical form, 6 had secondary progressive form, and 1
had primary progressive form.
HERV-W EXPRESSION DETECTION
As expected, most patients presented HERV-W envelope activity
in some level. Nine from ten samples tested presented medium
to high levels of HERV-W envelope expression, against very low
levels of expression (five individuals presented basal HERV-W
activity) or no activity at all (five individuals) in healthy controls,
confirming the association between MS and HERV-W activity
in our population. Although we did not sequence the cDNAs,
the Real-Time results suggest that is some variability among the
sequences, as indicated by variations in Tm’s of transcripts ampli-
fied from distinct patients (ranging from 76.1 to 77.6) (Nellåker
et al., 2006).
ERVWE2 GENETIC INVESTIGATION
Since the genomic reference sequence from ERVWE2 is truncated
due to a stop codon at position 39, we have searched for genetic
changes on the DNA of MS patients that could revert the stop
codon and produce a full- length protein. To do this, 896 bp of
ERVWE2 from 47 MS patients were amplified, sequenced and
compared to the genomic DNA from healthy individuals. We
found that all MS patients and healthy individuals included in
this study harbor a stop codon at position 39, thus preventing the
expression of a full-length Env protein. No significant additional
substitution was found in MS patients that differentiate them
from healthy individuals. GenBank IDs of sequences generated in
this study are JX293193-JX293276.
Because of the inability of ERVWE2 to produce a complete
ORF in both healthy andMS individuals, we then investigated the
genetic integrity of eleven additional HERV-W envelope copies
located at different chromosomes available on the GenBank. The
amino acid-translated genomic sequence from 6q21 HERV-W
and 2q11.2 copies also presented a stop codon at position 39,
and 17q12 envelope has a stop codon at position 34 (Figure 1).
Altogether, these data suggests that three of the five most active
HERV-W loci can only produce N-terminally truncated proteins.
Despite that ERVWE2 can produce only truncated proteins,
its expression is indubitable since has been repeatedly detected by
many authors. Since ERVWE2 lacks a formal promoter, the auto-
mated search for alternative promoter sequences in the vicinity
of the ERVWE2 was performed and revealed seven transcription
factors binding (TFB) sites with high probability (>0.8) to act as
FIGURE 1 | Multiple alignment of twelve HERV-W envelope proteins
located in distinct chromosome loci. Predicted signal peptides are shaded
in gray (Laufer et al., 2009). The thin box evidence the peptide corresponding
to coordinates 49–57 found to be similar to MOG epitope in Blastp analysis.
The arrow in the top indicates the stop codon at position 39, present in
Xq22.3, 6q21, and 2q11.2.
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regulatory elements located up to 1.6 kb upstream of the envelope
gene (three for AP-2, two for Sp1, one for NF-1, one GATA and
four putative TATA boxes) (Figure 2). One of them, the Sp1 at
position −1283 bp was identified with high posterior probability
in both prediction programs used.
HERV-W AND MYELIN SIMILARITY SEARCH
Because of the relatively high level of conservation among mem-
bers of HERV-W envelope genes from subfamily 3, Blastp analysis
were performed to compare the complete sequence of HERV-
W envelope protein encoded by virion-associated retroviral RNA
(MRSV type) (Komurian-Pradel et al., 1999; Perron et al., 2001)
to different isoforms of MBP, isoform 1 (EAW66598) and isoform
4 (EAW66598) andMOG (ID CAQ06616). Five retroviral regions
were found to have significant similarity to MOG (Expected
value = 0.1) (Figure 3), two of them are within the Ig-like
domain and were predicted as extracellular domain in Protein
Databank (PDB, at http://www.rcsb.org/pdb/protein/Q63345).
Interestingly, one of these extracellular regions (MOG66–79)
includes T and B cell epitopes, which are capable to induce both
T effectors functions and circulating Abs in rats (Ichikawa et al.,
1996).
The second region within the extracellular domain
(MOG91–99) shares six aminoacids to the retroviral enve-
lope (four identical and two with the same physical-chemical
properties) and was conserved among all loci previously associ-
ated to transcripts in MS patients, as illustrated in Figures 1, 3
(Laufer et al., 2009).
A single match was found between the MBP and retroviral
envelope that overlaps the region shared between HERV and
MOG in a helical domain (MOG215–225). Blastp of MBP isoform
4 and retroviral envelope did not result in significant matches.
Finally, since a cross-reactive response against MOG would be
induced through the cleavage of ERVWE2 and presentation to
MHC II, we also investigated for putative cleavage sites nearby
the shared epitopes of ERVWE2 and MOG. The analysis revealed
several sites with high probability to serve as proteasomic cleav-
age sites (35 putative regions in MOG and 87 in HERV-W). No
putative cleavage site was found nearby the region that matches
to MPB.
DISCUSSION
ERVEW2 ANALYSIS
Previous reports in this field focused on detection and char-
acterization of the HERV-W transcripts found in MS patients
(Garson et al., 1998; Blond et al., 1999a; Laufer et al., 2009;
Roebke et al., 2010; Perron et al., 2012). In fact, the HERV-W
Env detection in serum and brain of MS patients but not in
controls sustains the association of retroviral activation and the
disease (Perron et al., 2012). MSRV envelope transcripts come
from different chromosomal loci, but most of them are related to
the Xq22.3 chromosome (ERVWE2) (Laufer et al., 2009), which
lack the 5′ LTR, gag, and part of the polymerase. This locus
cannot account for retroviral particles associated with RT activ-
ity and MSRV subtype RNA as described (Perron et al., 1997;
Garson et al., 1998; Komurian-Pradel et al., 1999), unless alter-
native upstream promoter regions exist, or the expression is 3′
LTR-mediated.
Although the putative promoter regions need to be validated
in human samples, the presence of seven TFBs including Sp1 and
FIGURE 2 | Transcription factors binding sites (TFBs). TFBs and TATA
boxes were mapped through the 1580 upstream region before ATG of
the Xq22.3 envelope region. The seven putative regions are in bold and
italicized. The coordinate position and the name of the putative
transcription factor are also specified. Putative TATA boxes are italicized
and underlined.
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FIGURE 3 | Epitope regions shared between ERVWE2 envelope
and myelin proteins (MOG and MBP). The aminoacid alignment
was generated by Blastp tool and significant matches are shown.
Coordinate positions of each protein are indicated after
identification. Plus signals correspond to aminoacids having the
same polarity characteristics. The MOG peptides corresponding to
coordinates 66–79 and 91–99 are located at extracellular domain
of the protein.
AP-2 upstream the start codon of reference sequence identified
in this study could explain the high level of transcripts reported
despite the lack of 5′ LTR. Receptors for Sp1 protein are present
in several eukaryotic genes involved with cellular differentiation
and also in the LTRs of exogenous and endogenous retroviruses
(Urnovitz and Murphy, 1996). Also, both Sp1 and AP-2 partici-
pate in transcriptional activation or repression of HERV-W genes
in a tissue-dependent manner (Schön et al., 2001; Lee et al., 2003;
Prudhomme et al., 2004).
Nevertheless, the fact that the ERVWE2 could be transcribed
via alternative promoters does not mean that a functional protein
is produced since the ERVWE2 DNA is N-terminally truncated.
Intriguingly, some transcripts previously associated to this locus
harbored a tryptophan (TGG) at site 39 instead (Laufer et al.,
2009), suggesting that genetic polymorphism could allow the
transcription of a complete ORF in MS patients.
This is not the case however. By sequencing the ERVWE2
locus of 84 individuals, including nine MS patients with HERV-
W envelope activity detected in PMBC, we showed no evidence
of genetic polymorphism that could revert the stop codon in
any individual. Also, although our experiment to find retroviral
mRNA was not designed to discriminate the source of tran-
scripts, the slight Tm deviation among individuals may indicate
that transcripts came from distinct sources. Taken together, our
data support that retroviral transactivation may occur in distinct
chromosomal loci, and despite no 5′ LTR and the incapability
to generate a functional protein, ERVWE2 would be capable to
be transcribed via alternative promoters. Nevertheless, experi-
mental analyses of eventual alternative promoters will also be
required before final conclusions may be drawn about their
accuracy.
The reported detection of transcripts closely associated to this
chromosome but harboring a tryptophan at codon 39 suggests
two possible and non-exclusive explanations: (1) These mRNA
are recombinant products generated in vitro (Laufer et al., 2009);
and (2) The ERVWE2-associated mRNA were generated by an
unfixed provirus, which have been formed earlier in human
evolution and would then be represented by MSRV subtype
sequences, as associated with extracellular retroviral particles and
reverse-transcriptase (Dolei and Perron, 2009), In keeping with
this, the subfamily 3 (that includes syncytin and ERVWE2) com-
prises most of the HERV-W members by which the intense
activity extends to the last 5 million years (Costas, 2002). Thus, if
new elements were generated after this period (i.e., after the ori-
gin of the genusHomo) (Jones et al., 1994) theymay not have been
fixed in the human genome and are present in the population as
polymorphic insertions (Macfarlane and Simmonds, 2004).
HERV-W AND MOLECULAR MIMICRY
Usually, the immune system is tolerant to self-antigens, but in
autoimmune disease the tolerance is abrogated to these antigens,
leading to direct tissue damage mediated by immune response.
The reasons that lead to this autoimmunity are still unknown, but
viruses are good candidates to trigger this process.
The mechanisms by which viruses could induce autoimmunity
include the expression of superantigens and molecular mimicry,
whereas auto-reactive T cells are induced by epitopes shared
between pathogen and host (self-antigens) (Miller et al., 2001). In
this context, HERVs might act as both: encoding superantigens
thereby result in enhanced inflammatory responses or mimick-
ing self-antigens (Clausen, 2003; Rolland et al., 2006; Ogasawara
et al., 2010).
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As demonstrated before and confirmed here by in vitro and in
silico analysis, several HERV-W envelope, including ERVWE2 are
N-terminally truncated and do not produce a functional protein.
However, since the transcription of these proviruses was exhaus-
tively demonstrated, it is possible that simply expression and
formation of truncated proteins is sufficient to elicit an immune
response.
Alternatively, truncated ERVWE loci could skip the stop
codons by generating spliced mRNAs. Although little informa-
tion about HERV-W splicing is available (Blond et al., 1999b),
HERV-H spliced mRNA can be found almost exclusively in MS
patients (Christensen et al., 2003). There are also evidences of
a pathogenic potential of spliced syncytin-1, as demonstrated
by the presence of spliced mRNA in biopsies of testicular semi-
nomas (Trejbalová et al., 2011). Despite no current evidence
of spliced ERVWE mRNA in MS, one could hypothesize that
cell-specific splicing factors might be involved in ERVW alter-
native splicing in brain cells, allowing the synthesis of ERVWE2
mRNAs without the stop codon region. Nevertheless, we found
no evidence of donor and acceptor splicing sites in the ERVWE2
locus and its putative promoter region. Since the promoter
regions as well as myelin and retroviral envelope similarity
were predicted by in silico analyses only, further and dedi-
cated studies are now needed to better characterize the possible
involvement between HERV-W transcription and induction of
autoimmunity.
In conclusion, the involvement of HERV-W envelope to
the cross immunity in MS involves other element(s) than the
ERVWE2 locus expression itself. As demonstrated here, the sim-
ilarity between MOG and envelope is not restricted to the
ERVWE2 locus, but it is extended to several HERV-W enve-
lope genes from subfamily 3. It does imply that any HERV-W
envelope fromMRSV subfamily, together to other genetic or envi-
ronmental co-factors, could trigger the immune system leading
to a cross reaction against MOG. Additionally, the high hetero-
geneity among individuals and previous exposition to other viral
antigens may have some impact on the transactivation of HERV-
W proviruses and interfere with the activation of inflammatory
cytokines.
CONCLUDING REMARKS
From our present observations, molecular mimicry is likely to
provide an important avenue of research on these HERV proteins,
which could turn to explain why the immune system targets spe-
cific self-proteins in certain autoimmune diseases. Since HERVs
may be the molecular link between host’s genetic factors and
autoimmune diseases there is now a need for in-depth analy-
sis of the active loci in the human genome to better clarify the
role of these retroelements to the autoimmunity. Alternatively, if
an unfixed active element related to the HERV-W family or spe-
cific spliced mRNA are indeed related to MS pathogenesis, very
different methodological approaches must be considered for the
purpose of their molecular isolation in selected productive cells
from patients with MS.
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